New Developments in Stroke in HIV-infected Patients

doi:10.12114/j.issn.1007-9572.2019.00.103

Abstract

Abstract: With the wide application of highly active antiretroviral therapy （HAART），and the acceleration of HIV-infected population aging，studies about the relationship between stroke and HIV infection have received increasing attention.Stroke is considered to be a serious complication after HIV infection，with high mortality and disability.At present，the epidemiology and pathogenesis of the disease are not completely clear，and there are no effective prevention and treatment measures.This article reviews recent developments in epidemiology，pathogenesis，prevention and treatment，and TCM knowledge concerning HIV-infected patients with stroke，in order to provide a reference for the prevention and treatment of HIV-related stroke.

Key words: Acquired immunodeficiency syndrome, HIV, Stroke, Highly active antiroviral therapy, Complications, Review

摘要： 随着高效抗反转录病毒治疗（HAART）的广泛应用和人类免疫缺陷病毒（HIV）感染人口老龄化趋势的加快，脑卒中与HIV感染的相关性研究日益受到人们的关注。脑卒中被认为是HIV感染后较为严重的并发症，具有高病死率及致残率的特点。目前，HIV感染并发脑卒中的流行病学、发病机制方面尚未完全明确，同时缺乏有效的防治措施。本文综述近年来国内外关于HIV感染并发脑卒中的流行病学、发病机制、预防治疗以及中医认识等方面的研究进展，以期为HIV感染并发脑卒中的防治提供参考依据。

关键词: 获得性免疫缺陷综合征, HIV, 卒中, 高效抗反转录病毒治疗, 并发症, 综述

GAO Haibin,LI Zimu,TANG Beibei, et al. New Developments in Stroke in HIV-infected Patients　[J]. Chinese General Practice, 2019, 22(26): 3255-3259. DOI: 10.12114/j.issn.1007-9572.2019.00.103.
高海滨,李子木,唐蓓蓓等. 人类免疫缺陷病毒感染并发脑卒中研究新进展[J]. 中国全科医学, 2019, 22(26): 3255-3259. DOI: 10.12114/j.issn.1007-9572.2019.00.103.

References

［1］CORRAL I，QUEREDA C，MORENO A，et al．Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy：incidence and risk factors［J］．Cerebrovasc Dis，2009，27（6）：559-563．DOI：10.1159/000214219.
［2］DOBBS M R，BERGER J R.Stroke in HIV infection and AIDS［J］．Expert Rev Cardiovasc Ther，2009，7（10）：1263-1271．DOI：10.1586/erc.09.72.
［3］BENJAMIN L A，BRYER A，EMSLEY H C，et al．HIV infection and stroke：current perspectives and future directions［J］．Lancet Neurol，2012，11（10）：878-890．
［4］CONNOR M D，LAMMIE G A，BELL J E，et al．Cerebral infarction in adult AIDS patients：observations from the Edinburgh HIV Autopsy Cohort［J］．Stroke，2000，31（9）：2117-2126．DOI：10.1161/01.STR.31.9.2117.
［5］VINIKOOR M J，NAPRAVNIK S，FLORIS-MOORE M，et al．Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States［J］．AIDS Res Hum Retroviruses，2013，29（7）：1068-1074．
［6］QUIROS-ROLDAN E，RAFFETTI E，FOCà E，et al．Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade：a population-based study from 2000 to 2012［J］．AIDS Care，2016，28（12）：1551-1558．
［7］LUCHUO E B，NKOKE C.A new look at human immunodeficiency virus infection and stroke in Sub-Saharan Africa［J］．Ann Transl Med，2016，4（12）：246．DOI：10.21037/atm.2016.06.15.
［8］THAKUR K T，LYONS J L，SMITH B R，et al．Stroke in HIV-infected African Americans：a retrospective cohort study［J］．J Neurovirol，2016，22（1）：50-55．
［9］2011年中国艾滋病疫情估计［J］．中国艾滋病性病，2012，18（1）：1-5.
［10］CHOW F C，REGAN S，FESKE S，et al．Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system［J］．J Acquir Immune Defic Syndr，2012，60（4）：351-358．DOI：10.1097/qai.0b013e31825c7f24.
［11］CHOW F C，WILSON M R，WU K，et al．Stroke incidence is highest in women and non-Hispanic Blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort［J］．AIDS，2018，32（9）：1125-1135．DOI：10.1097/QAD.0000000000001799.
［12］CONNOR M D，LAMMIE G A，BELL J E，et al．Cerebral infarction in adult AIDS patients：observations from the Edinburgh HIV Autopsy Cohort［J］．Stroke，2000，31（9）：2117-2126．DOI：10.1161/01.STR.31.9.2117.
［13］EVERS S，NABAVI D，RAHMANN A，et al．Ischaemic cerebrovascular events in HIV infection：a cohort study［J］．Cerebrovasc Dis，2003，15（3）：199-205．
［14］COLE J W，PINTO A N，HEBEL J R，et al．Acquired immunodeficiency syndrome and the risk of stroke［J］．Stroke，2004，35（1）：51-56．
［15］GUO F，HSIEH E，LV W，et al．Cardiovascular disease risk among Chinese antiretroviral-na?ve adults with advanced HIV disease［J］．BMC Infect Dis，2017，17（1）：287．
［16］FEIGIN V L，LAWES C M，BENNETT D A，et al．Worldwide stroke incidence and early case fatality reported in 56 population-based studies：a systematic review［J］．Lancet Neurol，2009，8（4）：355-369．DOI：10.1016/S1474-4422（09）70025-0.
［17］TOMAZIC J，SILIC A，KARNER P，et al．Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients［J］．Wien Klin Wochenschr，2004，116（21/22）：755-759．
［18］FRIIS-M?LLER N，THIéBAUT R，REISS P，et al．Predicting the risk of cardiovascular disease in HIV-infected patients：the data collection on adverse effects of anti-HIV drugs study［J］．Eur J Cardiovasc Prev Rehabil，2010，17（5）：491-501．
［19］BENJAMIN L A，ALLAIN T J，MZINGANJIRA H，et al．The role of human immunodeficiency virus-associated vasculopathy in the etiology of stroke［J］．J Infect Dis，2017，216（5）：545-553．DOI：10.1093/infdis/jix340.
［20］SCH?CHINGER V，BRITTEN M B，ZEIHER A M.Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease［J］．Circulation，2000，101（16）：1899-1906．DOI：10.1161/01.CIR.101.16.1899.
［21］ALLIE S，STANLEY A，BRYER A，et al．High levels of von Willebrand factor and low levels of its cleaving protease，ADAMTS13，are associated with stroke in young HIV-infected patients［J］．Int J Stroke，2015，10（8）：1294-1296.
［22］HASER G C，SUMPIO B.Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy［J］．J Vasc Surg，2017，65（3）：849-859．DOI：10.1016/j.jvs.2016.01.036.
［23］MAGEN E，ELBIRT D，STHOEGER Z.Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus［J］．Isr Med Assoc J，2005，7（4）：252-256．
［24］KOTLER D P.Hepatitis C，human immunodeficiency virus and metabolic syndrome：interactions［J］．Liver Int，2009，29（S2）：38-46．DOI：10.1111/j.1478-3231.2008.01951.x.
［25］KULASEKARAM R，PETERS B S，WIERZBICKI A S.Dyslipidaemia and cardiovascular risk in HIV infection［J］．Curr Med Res Opin，2005，21（11）：1717-1725．
［26］BERKEFELD J，ENZENSBERGER W，LANFERMANN H.MRI in human immunodeficiency virus-associated cerebral vasculitis［J］．Neuroradiology，2000，42（7）：526-528．
［27］GOLDSTEIN D A，TIMPONE J，CUPPS T R.HIV-associated intracranial aneurysmal vasculopathy in adults［J］．J Rheumatol，2010，37（2）：226-233．
［28］SPUDICH S S，ANCES B M.CROI 2016：neurologic complications of HIV infection［J］．Top Antivir Med，2016，24（1）：
29-37.
［29］SMITH B.Toward understanding the when and why of human immunodeficiency virus-associated stroke［J］．J Infect Dis，2017，216（5）：509-510．DOI：10.1093/infdis/jix343.
［30］NAGEL M A.Varicella zoster virus vasculopathy：clinical features and pathogenesis［J］．J Neurovirol，2014，20（2）：157-163．DOI：10.1007/s13365-013-0183-9.
［31］NAGEL M A，TRAKTINSKIY I，AZARKH Y，et al．Varicella zoster virus vasculopathy：analysis of virus-infected arteries［J］．Neurology，2011，77（4）：364-370．
［32］PATIRA R，SMITH-BENJAMIN S，WANG J J.Stroke in a young patient with neurosyphilis and HIV［J］．Int J STD AIDS，2017，28（3）：306-309．DOI：10.1177/0956462416665029.
［33］YEN Y F，CHEN M，JEN I，et al．Association of HIV and opportunistic infections with incident stroke：a Nationwide Population-based Cohort Study in Taiwan［J］．J Acquir Immune Defic Syndr，2017，74（2）：117-125．
［34］BENJAMIN L A，BRYER A，LUCAS S，et al．Arterial ischemic stroke in HIV：defining and classifying etiology for research studies［J］．Neurol Neuroimmunol Neuroinflamm，2016，3（4）：e254．DOI：10.1212/NXI.0000000000000254.
［35］ZIMBA S，NTANDA P M，LAKHI S，et al．HIV infection，hypercoagulability and ischaemic stroke in adults at the University Teaching Hospital in Zambia：a case control study［J］．BMC Infect Dis，2017，17（1）：354．
［36］Raising awareness of antiphospholipid antibody syndrome［J］．Lancet，2010，375（9717）：778．
［37］MOCHAN A，MODI M，MODI G.Protein S deficiency in HIV associated ischaemic stroke：an epiphenomenon of HIV infection［J］．J Neurol Neurosurg Psychiatry，2005，76（10）：1455-1456．DOI：10.1136/jnnp.2004.059733.
［38］金栋.“卒中”病名考［J］．世界中西医结合杂志，2009，4（3）：156-158．DOI：10.3969/j.issn.1673-6613.2009.03.002.
［39］张久亮，李英姿，杨海英，等．脑卒中的中医传统病机分析［J］．中国中西医结合杂志，2012，32（1）：107-110．DOI：10.7661/CJIM.2012.1.107.
［40］TRIANT V A，LEE H，HADIGAN C，et al．Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease［J］．J Clin Endocrinol Metab，2007，92（7）：2506-2512．
［41］Strategies for Management of Antiretroviral Therapy（SMART）Study Group，EL-SADR W M，LUNDGREN J，et al．CD4+ count-guided interruption of antiretroviral treatment［J］．N Engl J Med，2006，355（22）：2283-2296．
［42］LINDLEY R，CoChair of Expert Working Group.Clinical guidelines for stroke management 2010［J］．Journal of Polymer Science Part A：Polymer Chemistry，2010，41（10）：1536-1544．
［43］SWEENEY E M，THAKUR K T，LYONS J L，et al．Outcomes of intravenous tissue plasminogen activator for acute ischaemic stroke in HIV-infected adults［J］．Eur J Neurol，2014，21（11）：1394-1399．DOI：10.1111/ene.12506.
［44］Cholesterol Treatment Trialists'（CTT） Collaboration，BAIGENT C，BLACKWELL L，et al．Efficacy and safety of more intensive lowering of LDL cholesterol：a meta-analysis of data from 170，000 participants in 26 randomised trials［J］．Lancet，2010，376（9753）：1670-1681．DOI：10.1016/S0140-6736（10）61350-5.
［45］PAPAGIANNI M，METALLIDIS S，TZIOMALOS K.Novel insights in the management of dyslipidemia in patients with HIV infection［J］．Curr Pharmacol Rep，2018，4（2）：112-119.
［46］丁彩霞，盛蕾，张兰坤，等．国医大师周仲瑛治疗中风后遗症验案赏析［J］．中华中医药杂志，2016，31（4）：1267-1269.
［47］孙立明，李岩，王宏业，等．火针临床优势病种的文献研究［J］．上海针灸杂志，2009，28（7）：428-432．DOI：10.13460/j.issn.1005-0957.2009.07.003.
［48］于学平，严姣，邹伟.肌张力分期针刺治疗中风偏瘫临床疗效观察［J］．中国针灸，2018，38（10）：1035-1038．DOI：10.13703/j.0255-2930.2018.10.002.
［49］唐卫华，张蓓蓓，丁砚兵.针药“病证结合”早期治疗急性缺血性中风的疗效观察［J］．中西医结合心脑血管病杂志，2018，16（18）：2733-2735．DOI：10.12102/j.issn.1672-1349.2018.18.044.

[1]	QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289.
[2]	SU Kaiqi, LYU Zhuan, WU Mingli, LUO Meng, GAO Jing, NIE Chenchen, LIU Hao, FENG Xiaodong. Effect of Electroacupuncture on BDNF/TrkB/PI3K/Akt Pathway and Hippocampal Neuronal Protection in Rats with Learning and Memory Impairment after Ischemia Reperfusion [J]. Chinese General Practice, 2023, 26(33): 4187-4193.
[3]	YIN Miaomiao, CUI Liling, LI Yaqing, WANG Liqun, ZHANG Yue, WU Jialing. Effect of Dual Task on Walking Ability in Posterior Circulation Ischemic Stroke Patients with Vestibular Symptoms [J]. Chinese General Practice, 2023, 26(33): 4207-4212.
[4]	JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079.
[5]	YANG Yuxuan, ZHANG Han, DU Juan, WANG Lingling, XIE Yulei, YIN Kaiming, ZHANG Bo. Value of an Dynamic Eye-tracking Task in Assessing Unilateral Spatial Neglect after Stroke [J]. Chinese General Practice, 2023, 26(32): 4020-4025.
[6]	GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037.
[7]	ZHU Lin, GUO Yankui, GAO Chen, CHEN Xuezhi, WANG Fashuai. Efficacy of Western Medicine, Chinese Patent Medicine and Their Combination on Post-stroke Insomnia: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3823-3832.
[8]	XIAO Yuqian, BAI Yanjie, WANG Yan, CHEN Shuying, CHEN Limin, SUN Kexin, WAN Jun. Research Progress of Mitochondrial Transfer in Post-stroke Cognitive Impairment [J]. Chinese General Practice, 2023, 26(30): 3833-3840.
[9]	LIU Yue, LIU Qi, DONG Hui, LIU Yaling. Neuropsychological Changes of Cognitive Reverters after Stroke Based on the Montreal Cognitive Assessment (MoCA) with a Double Threshold [J]. Chinese General Practice, 2023, 26(27): 3417-3422.
[10]	DONG Yanan, JIANG Xiaorui, WANG Kai, ZONG Chuanchong, LIN Guodong, LI Xiangqing, LIN Chunxiao, CHI Juntao. The Effect of Modified Tibial Transverse Transport Technique in the Treatment of Wagner Grade Ⅲ and Ⅳ Diabetic Foot Patients [J]. Chinese General Practice, 2023, 26(27): 3411-3416.
[11]	ZHENG Siting, HE Chunyu, ZHOU Jun, KONG Ye, YANG Xinyao, ZHOU Haiying, WEI Xiaofei. Summary of Best Evidence for Self-Management of Patients with Motor Dysfunction after Stroke [J]. Chinese General Practice, 2023, 26(26): 3230-3237.
[12]	Expert group of expert consensus on the application of ulinastatin in common clinical critical illness. Expert Consensus on the Application of Ulinastatin in Common Clinical Critical Illness [J]. Chinese General Practice, 2023, 26(26): 3207-3219.
[13]	WANG Xiaowen, XIAO Tongling, WANG Yi, YANG Ying, XIA Xiaoshuang, LI Xin. Relationship between Homocysteine Level and Acute Kidney Injury in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2023, 26(26): 3290-3296.
[14]	DU Yuying, WANG Cailing, CUI Senlin, LEI lei, WANG Yanping, SONG Xueqin, HAN Shuqin, ZHANG Yanmei, WANG Baolan, HUANG Haixia, CHEN Mi, YAN Huirong, LI Dong, ZHANG Jingjing, REN Yu. Analysis of Appropriate Technology Promotion for Stroke Rehabilitation in Southern Xinjiang [J]. Chinese General Practice, 2023, 26(25): 3178-3184.
[15]	ZHANG Guoqing, TONG Tingting, WANG Ying, LI Kuiwu, ZHANG Lida, WU Xiaoqing, LI Chenglong, WANG Junli, ZHANG Junyu, HAN Wei. Effect and Mechanism of Tongdu Tiaoshen Electroacupuncture Pretreatment-mediated MiR-124-3p/GSK-3β/Cyp-D Signaling Pathway on Mitochondrial Permeability Transition Pore in Cerebral Cortex of Rats with Cerebral Ischemia-reperfusion Injury [J]. Chinese General Practice, 2023, 26(24): 3050-3060.